Not applicableStudy completedNCT02747017What this trial is testingObservational Study of C. Diff in Post-Transplant PatientsWho this might be right forClostridium Difficile University of Minnesota 132
Large-scale testing (Phase 3)Study completedNCT05831189What this trial is testingA Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)WithdrawnNCT03643887What this trial is testingPhase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE PatientsWho this might be right forClostridium Difficile Infection University of Wisconsin, Madison
Not applicableStudy completedNCT02461901What this trial is testingDoes Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?Who this might be right forClostridium Difficile Infection Professor Mark Wilcox 203
Not applicableUnknownNCT06258551What this trial is testingDynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill PatientsWho this might be right forAntimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more The Methodist Hospital Research Institute 1,000
Not applicableLooking for participantsNCT07235228What this trial is testingEffects of Vivatlac Synbiotic on Gut Micribiota of IBS PatientsWho this might be right forIrritable Bowel Syndrome The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz 20
Testing effectiveness (Phase 2)WithdrawnNCT01077245What this trial is testingSafety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile InfectionsWho this might be right forClostridium Difficile Infection Osel, Inc.
Testing effectiveness (Phase 2)Study completedNCT00382304What this trial is testingThe Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaWho this might be right forPseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea Genzyme, a Sanofi Company 24
Large-scale testing (Phase 3)Study completedNCT05320068What this trial is testingOral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's InfectionWho this might be right forClostridioides Difficile Infection Julia Orígüen 24
Not applicableStudy completedNCT00446355What this trial is testingClinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC GenotypesWho this might be right forClostridium Infections University of Pittsburgh 1,000
Post-approval studies (Phase 4)Study completedNCT02254967What this trial is testingA Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older PopulationWho this might be right forClostridium Difficile Astellas Pharma Europe Ltd. 364
Large-scale testing (Phase 3)WithdrawnNCT07221708What this trial is testingPrimary Prophylaxis of Clostridioides Difficile Infection With Oral VancomycinWho this might be right forClostridioides DifficileVancomycin Resistance Enterococcus Faecium University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT02052726What this trial is testingInvestigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.Who this might be right forClostridium Difficile Pfizer 184
Large-scale testing (Phase 3)Ended earlyNCT01226992What this trial is testingOral Vancomycin Followed by Fecal Transplant Versus Tapering Oral VancomycinWho this might be right forRecurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection University Health Network, Toronto 81
Not applicableEnded earlyNCT01533844What this trial is testingTo Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the PathogenesisWho this might be right forClostridium Difficile Astellas Pharma Europe B.V. 1
Early research (Phase 1)Study completedNCT01551004What this trial is testingPhase I Trial of a Single Dose of CRS3123Who this might be right forClostridium Difficile Colitis National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)UnknownNCT03988855What this trial is testingAn Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile InfectionWho this might be right forClostridium Difficile (C. Difficile) Deinove 40
Early research (Phase 1)Study completedNCT03827447What this trial is testingVancomycin for the Treatment of NAAT(+)/Toxin(-) C. DifficileWho this might be right forClostridium Difficile Infection Medical College of Wisconsin 7
Early research (Phase 1)Study completedNCT02981316What this trial is testingTreatment of Recurrent Clostridium Difficile Infection With RBX7455Who this might be right forClostridium Difficile Infection Mayo Clinic 30
Early research (Phase 1)Looking for participantsNCT07401680What this trial is testingFecal Microbiota Transplantation in an Expanded Ulcerative Colitis PopulationWho this might be right forUlcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection University of Alberta 85